QTRX Nasdaq Laboratory Analytical Instruments Financials FY2016βFY2025
Quanterix Corp had $139M of revenue in fiscal 2025, up 1.1% on the year before. Over five years, revenue changed +10.0% a year on average.
Last close Β· Oct 23, 2026
$2.86
0.7%Hi! I read Quanterix Corpβs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+1.1%
Only a little. Sales grew 1.1% last year.
Does it make a profit?
β77.1%
No. It lost money last year.
Does profit turn into cash?
β57.5%
No. It spent more cash than it brought in.
How healthy are the accounts?
1 / 8
Weak. It passes 1 of 8 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA Β· Quanterix Corp had $139M of revenue in fiscal 2025, up 1.1% on the year before. Over five years, revenue changed +10.0% a year on average. Its operating margin was β90.4%, down 52.1Β pts: of every 100 in sales, about β90 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Quanterix Corp lost $107M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$79.8M in fiscal 2025, β57.5% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· In the last 12 months, insiders bought $0.3M of shares on the open market and sold none.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.3M
2 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably Quanterix Corp can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $396M | $339M | $181M | $56.7M | $118M |
| Current ratio | 12.1x | 12.2x | 9.8x | 8.7x | 2.8x |
| Quick ratio | 11.5x | 11.6x | 9.1x | 7.9x | 2.1x |
| Total assets | $502M | $434M | $429M | $407M | $419M |
| Total liabilities | $60.6M | $75.7M | $78.6M | $76.5M | $123M |
| Shareholders' equity | $443M | $358M | $350M | $330M | $296M |
| Net debt (β = net cash) | β | β | β | β | β |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Quanterix Corp passes 1 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 3 / 9 | 4 / 9 | 4 / 9 | 4 / 8 | 3 / 8 | 4 / 8 | 2 / 8 | 1 / 8 |
| Accruals ratio | β | β5.4% | β3.5% | β12.3% | β3.7% | β2.1% | β10.9% | β2.2% | β0.8% | β7.2% |
| Altman Z'' | β | 0.61 | β5.98 | 1.83 | 3.92 | 10.32 | 5.62 | 5.92 | 5.08 | β1.83 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $17.6M | $22.9M | $37.6M | $56.7M | $86.4M | $111M | $106M | $122M | $137M | $139M |
| Net interest income | β$1.3M | β$1.0M | $0.0M | $0.6M | β$0.3M | β$0.4M | $5.1M | $15.8M | $14.7M | $8.6M |
| Provision for credit losses | β | β | β | β | $0.5M | $0.2M | $0.8M | $0.7M | $0.7M | $1.5M |
| Gross profit | $7.7M | $10.0M | $17.9M | $26.8M | $48.2M | $64.8M | $45.4M | $74.2M | $83.1M | $65.0M |
| Research and development | $17.0M | $16.3M | $15.8M | $16.2M | $20.2M | $28.4M | $26.8M | $26.1M | $31.1M | $35.9M |
| Operating income | β$21.7M | β$26.0M | β$31.6M | β$41.6M | β$31.6M | β$56.5M | β$104M | β$46.0M | β$52.6M | β$126M |
| Pretax income | β$23.2M | β$27.0M | β$31.5M | β$41.0M | β$31.9M | β$55.6M | β$99.4M | β$27.6M | β$38.1M | β$112M |
| Income tax | β | $0.0M | $0.0M | β$0.2M | β$0.4M | β$0.0M | $0.2M | $0.7M | $0.4M | β$5.1M |
| Net income | β$23.2M | β$27.0M | β$31.5M | β$40.8M | β$31.5M | β$55.5M | β$99.6M | β$28.4M | β$38.5M | β$107M |
| Net income to common | β$27.6M | β$31.2M | β$31.5M | β$40.8M | β | β | β | β | β | β |
| Diluted EPS | β | β | β | β$1.63 | β$1.07 | β$1.54 | β$2.69 | β$0.75 | β$1.00 | β$2.51 |
| Diluted shares | 0.00B | 0.00B | 0.02B | 0.03B | 0.03B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B |
| Cash flow | ||||||||||
| Cash from operations | β$17.7M | β$22.1M | β$28.7M | β$26.2M | β$23.4M | β$47.6M | β$48.6M | β$18.8M | β$35.2M | β$77.2M |
| Capital expenditure | $0.5M | $1.1M | $1.5M | $10.8M | $3.9M | $13.7M | $11.6M | $3.8M | $3.4M | $2.6M |
| Free cash flow | β$18.3M | β$23.2M | β$30.2M | β$37.0M | β$27.3M | β$61.3M | β$60.2M | β$22.7M | β$38.5M | β$79.8M |
| Depreciation and amortization | $0.4M | $0.5M | $1.4M | $3.0M | $4.3M | $4.9M | $5.4M | $6.3M | $6.5M | $15.8M |
| Stock-based compensation | $0.9M | $2.2M | $4.9M | $6.4M | $10.1M | $16.0M | $15.4M | $16.8M | $20.0M | $20.7M |
| Acquisitions | $0.3M | β | $3.8M | $14.5M | β | β | β | $0.0M | $0.0M | $93.2M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $29.7M | $79.7M | $44.4M | $109M | $182M | $396M | $339M | $181M | $56.7M | $118M |
| Total debt | β | $9.4M | $7.8M | $7.7M | $7.7M | β | β | β | β | β |
| Current assets | β | $89.3M | $59.5M | $133M | $220M | $449M | $382M | $382M | $364M | $212M |
| Current liabilities | β | $19.7M | $18.1M | $19.8M | $39.8M | $37.0M | $31.3M | $39.0M | $42.0M | $74.8M |
| Inventory | β | $3.6M | $5.9M | $10.5M | $14.9M | $22.2M | $17.0M | $26.1M | $32.8M | $54.8M |
| Property and equipment, net | β | $1.9M | $2.9M | $12.0M | $13.9M | $18.0M | $19.8M | $17.9M | $17.2M | $23.7M |
| Goodwill | β | β | $1.3M | $9.4M | $10.5M | $9.6M | $0.0M | $0.0M | $0.0M | $26.4M |
| Intangible assets | β | β | $2.3M | $14.3M | $13.7M | $10.5M | $7.5M | $6.0M | $4.0M | $132M |
| Total assets | β | $91.8M | $67.6M | $170M | $271M | $502M | $434M | $429M | $407M | $419M |
| Total liabilities | β | $25.9M | $26.5M | $41.3M | $64.9M | $60.6M | $75.7M | $78.6M | $76.5M | $123M |
| Shareholders' equity | β$115M | $65.9M | $41.1M | $129M | $206M | $443M | $358M | $350M | $330M | $296M |
| Margins | ||||||||||
| Gross margin | 44.1% | 43.7% | 47.7% | 47.3% | 55.8% | 58.6% | 43.0% | 60.7% | 60.5% | 46.8% |
| Operating margin | β123.5% | β113.7% | β83.8% | β73.3% | β36.6% | β51.1% | β98.8% | β37.6% | β38.3% | β90.4% |
| EBITDA margin | β120.9% | β111.6% | β80.2% | β68.0% | β31.6% | β46.7% | β93.7% | β32.5% | β33.6% | β79.0% |
| Net margin | β131.8% | β118.1% | β83.8% | β71.9% | β36.5% | β50.2% | β94.4% | β23.2% | β28.0% | β77.1% |
| FCF margin | β103.9% | β101.6% | β80.4% | β65.3% | β31.6% | β55.4% | β57.1% | β18.5% | β28.0% | β57.5% |
| Net interest share of revenue | β7.4% | β4.2% | 0.1% | 1.1% | β0.3% | β0.4% | 4.9% | 12.9% | 10.7% | 6.2% |
| Returns | ||||||||||
| Return on capital | β | β | β566.6% | β120.9% | β78.1% | β | β | β | β | β |
| Return on capital employed | β | β36.1% | β63.8% | β27.7% | β13.7% | β12.2% | β25.9% | β11.8% | β14.4% | β36.5% |
| Return on equity | β | β | β59.0% | β48.1% | β18.9% | β17.1% | β24.9% | β8.0% | β11.3% | β34.2% |
| Return on assets | β | β29.4% | β39.6% | β34.3% | β14.3% | β14.4% | β21.3% | β6.6% | β9.2% | β26.0% |
| Return on tangible equity | β | β47.4% | β84.3% | β38.9% | β17.4% | β13.1% | β28.4% | β8.2% | β11.8% | β77.9% |
| Growth | ||||||||||
| Revenue growth | β | 30.1% | 64.5% | 50.8% | 52.2% | 28.0% | β4.6% | 16.0% | 12.3% | 1.1% |
| Share count change | β | 75.3% | 485.4% | 14.1% | 17.9% | 21.7% | 2.8% | 1.6% | 2.1% | 11.1% |
| Financial health | ||||||||||
| Debt / equity | β | 0.1x | 0.2x | 0.1x | 0.0x | β | β | β | β | β |
| Current ratio | β | 4.5x | 3.3x | 6.7x | 5.5x | 12.1x | 12.2x | 9.8x | 8.7x | 2.8x |
| Quick ratio | β | 4.3x | 3.0x | 6.2x | 5.1x | 11.5x | 11.6x | 9.1x | 7.9x | 2.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.0% | 4.9% | 4.0% | 19.1% | 4.5% | 12.4% | 11.0% | 3.1% | 2.5% | 1.9% |
| Stock comp / revenue | 5.3% | 9.5% | 13.0% | 11.3% | 11.7% | 14.4% | 14.6% | 13.7% | 14.5% | 14.9% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | 3.0 | 4.0 | 4.0 | 4.0 | 3.0 | 4.0 | 2.0 | 1.0 |
| Altman Z'' | β | 0.6 | β6.0 | 1.8 | 3.9 | 10.3 | 5.6 | 5.9 | 5.1 | β1.8 |
| Accruals ratio | β | β5.4% | β3.5% | β12.3% | β3.7% | β2.1% | β10.9% | β2.2% | β0.8% | β7.2% |
Source: SEC EDGAR XBRL filings (CIK 0001503274). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
